Locations:

Tag: ash17

December 12, 2017/Cancer/Research

Survivorship Care Plans Reduce Treatment Distress (Video)

Multicenter, randomized study of hematopoietic cell transplant survivors

December 11, 2017/Cancer/Research

Exploiting Vulnerability of Impaired DNA Repair Creates New Therapeutic Strategy in Acute Myeloid Leukemia

Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib

December 11, 2017/Cancer/Research

Long-Term Follow-Up of ZUMA-1 Shows Significant Clinical Benefit (Video)

Anti-CD19 CAR T cell therapy an option for patients with no others

December 10, 2017/Cancer/Research

Predictors of 30-day Unplanned Readmissions in Patients with Hematologic Malignancies

Disease-related, clinical and discharge-associated factors

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 10, 2017/Cancer/Research

The Cost of Chronic Graft Versus Host Disease

A cross-sectional survey from the Chronic GVHD Consortium

December 10, 2017/Cancer/Research

Autologous Hematopoietic Cell Transplant Improves Survival in Mantle Cell Lymphoma

Multicenter study shows survival benefit for patients ≤ 65

December 9, 2017/Cancer/Research

In Myelofibrosis, New Possibilities for Minimizing Symptoms and Drug Side Effects

JAK inhibitors, the hedgehog pathway and answers for anemia

December 9, 2017/Cancer/Research

Cancer Patients with VTE Treated in ED Face Higher Mortality Risks

Prevention, early detection best strategy

December 9, 2017/Cancer/Research

A Precise, Personalized Prediction Model for Risk Stratification of Patients with Myelodysplastic Syndromes

Researchers add genomic data to their model

BackPage 1 of 1Next